Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Gottschlich

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Leukemia|June 1, 2026
TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretomeLis Winter, Lea Pawlowsky, Amelie Muth, et al.
Scientific Reports|May 18, 2026
Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretionAlexandra S Triebig, Tanja Maier, Paul Schwarzlmueller, et al.
Gastroenterology|February 15, 2026
STING ablation in T cells is required for the efficacy of STING agonists in CAR-T cell immunotherapy of pancreatic cancerIgnazio Piseddu, Rebekka Endres, Fabian Lanzl, et al.
The Journal of Clinical Investigation|May 2, 2022
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancerUta M Demel, Marlitt Böger, Schayan Yousefian, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomaFlorian Märkl, Mohamed-Reda Benmebarek, Julius Keyl, et al.
Science Advances|June 10, 2021
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumorsBruno L Cadilha, Mohamed-Reda Benmebarek, Klara Dorman, et al.
Nature Biomedical Engineering|February 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumoursJanina Dörr, Lisa Gregor, Sebastian B Lacher, et al.
Cancer Discovery|June 11, 2025
Gut microbiota modulation through Akkermansia spp. supplementation increases CAR-T cell potencyLaura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil, et al.
Immunity|January 11, 2023
T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasisDaria Briukhovetska, Javier Suarez-Gosalvez, Cornelia Voigt, et al.
Nature Medicine|May 21, 2024
Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromesKami Pekayvaz, Corinna Losert, Viktoria Knottenberg, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Leukemia|June 1, 2026
TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretomeLis Winter, Lea Pawlowsky, Amelie Muth, et al.
Scientific Reports|May 18, 2026
Glucocorticoids induce a phagocytic C1Q+ macrophage phenotype primed for IFNγ-dependent CXCL9 secretionAlexandra S Triebig, Tanja Maier, Paul Schwarzlmueller, et al.
Gastroenterology|February 15, 2026
STING ablation in T cells is required for the efficacy of STING agonists in CAR-T cell immunotherapy of pancreatic cancerIgnazio Piseddu, Rebekka Endres, Fabian Lanzl, et al.
The Journal of Clinical Investigation|May 2, 2022
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancerUta M Demel, Marlitt Böger, Schayan Yousefian, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanomaFlorian Märkl, Mohamed-Reda Benmebarek, Julius Keyl, et al.
Science Advances|June 10, 2021
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumorsBruno L Cadilha, Mohamed-Reda Benmebarek, Klara Dorman, et al.
Nature Biomedical Engineering|February 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumoursJanina Dörr, Lisa Gregor, Sebastian B Lacher, et al.
Cancer Discovery|June 11, 2025
Gut microbiota modulation through Akkermansia spp. supplementation increases CAR-T cell potencyLaura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil, et al.
Immunity|January 11, 2023
T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasisDaria Briukhovetska, Javier Suarez-Gosalvez, Cornelia Voigt, et al.
Nature Medicine|May 21, 2024
Multiomic analyses uncover immunological signatures in acute and chronic coronary syndromesKami Pekayvaz, Corinna Losert, Viktoria Knottenberg, et al.
Pageof 4